Lecture Delivery & Question Type | GLOBAL | GENDER | CLINICAL TRAINING | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Median & IQR | p-value | Females Median & IQR | p-value | Males Median & IQR | p-value | Preclinical Median & IQR | p-value | Clinical Median & IQR | p-value | |||||||||||
Rec SAQ | 76.00 (66.00–84.00) | 0.110 | 77.78 (68.00-86.17) | 0.794 | 74.00 (61.00–80.00) | 0.034 | 76.00 (68.00-86.67) | 0.001 | 75.00 (64.00–82.00) | 0.368 | ||||||||||
F2F SAQ | 80.00 (64.00–88.00) | 80.00 (64.00-88.08) | 78.17 (64.25–87.67) | 84.00 (73.33–86.59) | 75.00 (58.00–84.00) | |||||||||||||||
CK-REC SAQ | 75.00 (62.50-90.91) | 0.034 | 80.00 (65.00-93.33) | 0.019 | 73.40 (60-38-86.20) | 0.621 | 73.33 (55.21–86.59) | 0.439 | 80.00 (66.67–93.33) | 0.001 | ||||||||||
CK-F2F SAQ | 80.00 (60.00–90.00) | 76.47 (60.00–90.00) | 79.20 (47.20-88.46) | 84.61 (37.50-93.33) | 79.00 (60.00-87.20) | |||||||||||||||
AK-REC SAQ | 75 (56.67–88.89) | 0.043 | 76.47 (60.00–90.00) | 0.330 | 72.20 (50.00- 88.22) | 0.05 | 75.96 (35.85-92.00) | 0.061 | 75.00 (61.54–85.71) | 0.264 | ||||||||||
AK-F2F SAQ | 80 (60.00-91.67) | 75.00 (60.00-92.72) | 80.0 (53.33- 90.00) | 80.00 (48.75–91.67) | 75.00 (60.36–90.20) | |||||||||||||||
Rec MCQ | 60.52 (52.63–68.42) | 0.03 | 60.52 (52.63–72.36) | 0.071 | 60.52 (46.05–67.10) | 0.273 | 60.53 (52.63–68.42) | 0.030 | N/A | |||||||||||
F2F MCQ | 72.72 (65.91–81.82) | 72.72 (65.91–81.82) | 72.73 (59.09–79.54) | 72.72 (65.90-81.82) | ||||||||||||||||
CK-REC MCQ | 69.23 (55.77–84.61) | 0.148 | 73.07 (55.77–84.62) | 0.239 | 69.23 (57.69–80.77) | 0.465 | 69.23 (55.78–84.61) | 0.148 | N/A | |||||||||||
CK-F2F MCQ | 80 (70.00–90.00) | 80 (70.00–90.00) | 80.00 (57.50–87.50) | 80.00 (70.00–90.00) | ||||||||||||||||
AK-REC MCQ | 40.62 (22.40-58.84) | 0.658 | 41.67 (33.33-50.00) | 0.723 | 33.33 (20.83–45.83) | 0.713 | 33.33 (33.33-50.00) | 0.659 | N/A | |||||||||||
AK-F2F MCQ | 31.25 (13.03–49.47) | 33.3 (17.36–49.24) | 20.00 (0.0–75.00) | 0.00 (0.00-100.00) |